Today: 13 June 2026
Palantir stock price rebounds to $135.90 on Cognizant AI deal — what to watch next week

Palantir stock price rebounds to $135.90 on Cognizant AI deal — what to watch next week

New York, Feb 7, 2026, 07:27 EST — The market has closed.

  • Palantir shares wrapped up Friday at $135.90, marking a roughly 4.5% gain compared to Thursday’s finish.
  • Cognizant’s TriZetto arm is set to roll out Palantir Foundry and AIP across its healthcare and business-process operations.
  • Next week’s U.S. jobs and inflation data may shake up rate expectations—key drivers for high-growth software names.

Shares of Palantir Technologies Inc finished Friday’s session at $135.90, gaining roughly 4.5% from the previous day’s $130.01 close. The stock’s 52-week span—anywhere from $66.12 up to $207.52—shows just how fast sentiment shifts in the AI software space.

The mood is splintering. Investors are starting to pick favorites, backing companies behind AI infrastructure while turning away from others that could be left behind, Reuters said. Some software stocks have taken particularly hard hits. “This divergence is not a vote against AI,” wrote Charu Chanana at Saxo. reuters.com

The calendar is back in focus. On Wednesday, Feb. 11, at 8:30 a.m. ET, investors will get the U.S. Employment Situation report for January. Two days later, Friday, Feb. 13 at the same hour, the Consumer Price Index lands—a data point closely watched for its influence on household costs and, frequently, Federal Reserve outlook.

Cognizant plans to roll Palantir Foundry—along with Palantir’s Artificial Intelligence Platform (AIP)—into its TriZetto healthcare unit and BPaaS (business-process-as-a-service) offering, the company said Thursday. “This partnership … will enable us to deliver secure, scalable AI solutions,” said Surya Gummadi, president of Cognizant Americas. Palantir’s Eric Lakin weighed in: “Enterprise AI doesn’t fail because models are weak.” Terms of the deal weren’t shared. news.cognizant.com

Palantir picked up steam along with a wider risk-on move heading into the weekend. The Dow Jones Industrial Average surged, finishing above 50,000 for the first time Friday after a rapid U.S. stock rally, according to Reuters.

No relief in sight for software stocks. According to Reuters, the S&P 500 software and services index has lost roughly $1 trillion in value since Jan. 28—a plunge some have started calling “software-mageddon.” “Calling the bottom during a crash in sentiment like this is very, very challenging,” said Dave Harrison Smith, chief investment officer at Bailard. reuters.com

Company headlines have been pushing against the broader market trend. Palantir notched a sharp increase in quarterly sales earlier this week, fueled by higher U.S. defense spending. According to Reuters, revenue from its U.S. government business climbed 66% in the fourth quarter, hitting $570 million. The shares initially rallied on the news, but later slipped again as investors focused back on valuation concerns and broader sector jitters.

The Cognizant partnership isn’t a straightforward boost for earnings. Turning pilots into consistent revenue streams with big partners often drags on, and any hint of softer growth has drawn swift backlash from investors in software names.

Palantir’s Friday rebound is under scrutiny—traders want to see if those gains stick when markets open Monday. The company’s fate may also hinge on whether deal announcements are enough to keep its stock from getting lumped in with the rest of the AI pack.

Stock Market Today

  • CSL Shares Rise 9.8% After FY26 Guidance Cut on Impairments and Channel Shifts
    June 13, 2026, 5:50 AM EDT. CSL (ASX:CSL) shares climbed 9.8% following a downward revision of its FY26 revenue and profit forecasts. The revision reflects impairments and writedowns linked to changes in U.S. immunoglobulin sales channels and weakening albumin prices in China. Despite these challenges, investor sentiment shows cautious optimism about CSL's operational turnaround prospects. The market now awaits CSL's full-year results and dividend update on 18 August 2026, which will offer clarity on revenue trends and any further impairments. CSL projects FY29 revenue of US$16.9 billion and earnings of US$3.3 billion, suggesting a potential 31% upside to current share prices. However, risks remain around sustained margin pressure and additional write-downs in plasma and albumin segments.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 13.06.2026

13 June 2026
LIVEMarkets rolling coverageStarted: June 13, 2026, 4:00 AM EDTUpdated: June 13, 2026, 6:12 AM EDT CSL Shares Rise 9.8% After FY26 Guidance Cut on Impairments and Channel Shifts June 13, 2026, 5:50 AM EDT. CSL (ASX:CSL) shares climbed 9.8% following a downward revision of its FY26 revenue and profit forecasts. The revision reflects impairments and writedowns linked to changes in U.S. immunoglobulin sales channels and weakening albumin prices in China. Despite these challenges, investor sentiment shows cautious optimism about CSL’s operational turnaround prospects. The market now awaits CSL’s full-year results and dividend update on 18 August 2026, which will offer
SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

13 June 2026
SGH closed at A$41.51, up 0.70% but underperformed the S&P/ASX 200’s 1.98% surge, as investors weighed solid cash flow and Boral margin gains against a high 36.03 P/E, mixed demand, and M&A risk; the next key catalyst is FY26 results on August 11, with analysts’ average target at A$47.64, 14.76% above Friday’s close.
Exxon Mobil stock price just tagged a new high — what could move XOM when markets reopen
Previous Story

Exxon Mobil stock price just tagged a new high — what could move XOM when markets reopen

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive
Next Story

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

Go toTop